The University of Oxford has partnered with a major UK pharmaceutical company to manufacture and distribute vaccines on a large scale.

The University of Oxford has partnered with the UK's largest pharmaceutical company, Estrazinica, to develop and distribute the vaccine on a large scale. Is provided immediately.

Sir John Bell, professor of medicine at Oxford University, told BBC Radio 4 that the results of the human test would be available in mid-June.                                                                                              He said that if approved by the vaccine watchdog, the biggest challenge would be widespread preparation. He said he wanted to make sure the world could develop the vaccine on that scale. It should be able to easily reach developing countries where it is most needed.

According to the university, the two sides have agreed to provide the vaccine on a not-for-profit basis during the epidemic, which means that only the costs of developing and delivering the vaccine will be borne.